Condition
Breast Cancer Early Stage Breast Cancer (Stage 1-3) clinical trials and research
As of November 12, 2026, Find a Trial lists 26 Breast Cancer Early Stage Breast Cancer (Stage 1-3) clinical trials that are recruiting, at sites in 12 countries (most in China (5), Italy (4), Spain (3)). 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 26Clinical trials
- 1New in 30 days
- 12Countries
Newest Breast Cancer Early Stage Breast Cancer (Stage 1-3) clinical trials
All recruiting trials (26)
-
Regular exercise to help women with early-stage breast cancer on hormone therapy
This study tests whether a guided, 16-week exercise program improves quality of life and fitness for women with early-stage breast cancer who are starting adjuvant hormone therapy.
-
Neoadjuvant Pyrotinib-to-pertuzumab for HER2-positive early breast cancer
This trial tests whether a two-step neoadjuvant plan with Pyrotinib plus Trastuzumab and Docetaxel followed by Pertuzumab plus Trastuzumab and Docetaxel works better than four cycles of Pertuzumab plus Trastuzumab and Docetaxel in women with HER2-positive early- to locally advanced breast cancer.
-
Time‑restricted eating (8‑hour window) during chemotherapy for breast cancer: feasibility and acceptability
This trial will test whether eating all daily food within an 8‑hour window is practical and acceptable for people starting chemotherapy for stage I–III breast cancer (and some stage IV with oncologist approval).
-
CPAP-assisted radiotherapy to lower heart and lung dose after breast-conserving surgery
This tests whether wearing a CPAP breathing device during adjuvant radiotherapy can lower radiation exposure to the heart and lungs for women with early-stage (stage 1–3) breast cancer who had breast‑conserving surgery.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients: Geriatric Screening in Action
This study tests whether using geriatric screening alongside adjuvant CDK4/6 inhibitors helps tailor therapy for adults aged 70 and older with early-stage breast cancer.
-
ScarWork to treat long-term breast pain after surgery
This trial will try ScarWork, a gentle manual scar therapy, to see if it reduces persistent breast pain in adults treated for early-stage breast cancer.
-
Multimodal prehabilitation combining exercise, nutrition, and psychological support to improve chemotherapy response in early breast cancer
This trial will try a combined program of exercise, nutrition, and psychological support during neoadjuvant chemotherapy to see if it improves tumor response in women with early-stage (I–III) breast cancer.
-
HUAXI Hole 1–assisted reverse‑sequence endoscopic nipple‑sparing mastectomy with immediate implant reconstruction
This project will test whether adding a 2‑mm 'HUAXI Hole 1' near the areola makes reverse‑sequence endoscopic nipple‑sparing mastectomy with direct‑to‑implant reconstruction faster, safer, and more cosmetic for women with early‑stage breast cancer or undergoing prophylactic mastectomy.
-
ctDNA-guided reduction of chemotherapy using dalpiciclib plus endocrine therapy in high-risk HR+/HER2- early breast cancer
This trial tests whether giving the CDK4/6 drug dalpiciclib with endocrine therapy and using ctDNA results can let some women with early high-risk HR+/HER2- breast cancer skip or reduce chemotherapy.
-
Judicious heart monitoring during HER2-targeted therapy for breast cancer
This study tests a personalized heart-monitoring plan during HER2-positive breast cancer treatment to see if fewer, risk-tailored heart tests can safely replace routine quarterly imaging.
-
SHR-A1811 and pertuzumab before surgery for HER2-positive breast cancer
This study tests whether adding SHR-A1811 to pertuzumab, with or without albumin-paclitaxel, helps people with early HER2-positive breast cancer reach a pathologic complete response before surgery.
-
Fezolinetant for hot flashes in women with early-stage, hormone receptor–positive breast cancer on endocrine therapy
This trial will test whether taking fezolinetant 45 mg daily can reduce moderate-to-severe hot flashes in women with early-stage, HR+ breast cancer who are on tamoxifen or aromatase inhibitors.
-
Using a specific position during radiotherapy for left breast cancer patients
This study is testing if a specific way of lying down during radiotherapy can help women with left breast cancer get better treatment while protecting their other organs.
-
Nutrition intervention's effect on breast cancer patients' bioimpedance phase angle
This study is testing if giving special nutritional supplements to women with early-stage breast cancer before and after surgery can help them recover better and improve their health.
-
Single vs. short-course radiation for partial breast cancer
This trial tests whether a single-fraction partial breast irradiation is as effective and tolerable as the standard multi-fraction approach for women 40 and older with early-stage breast cancer.
-
Robotic-assisted nipple-sparing mastectomy for breast cancer
This study is testing if robotic-assisted nipple-sparing mastectomy is a safe and effective option for women with early-stage breast cancer or those at high risk, compared to traditional surgery.
-
Adjuvant Treatment in Premenopausal Breast Cancer (Oncotype DX-Based)
This study looks at how premenopausal women with early breast cancer who had the Oncotype DX test were treated after surgery and what their outcomes were.
-
Evaluating Circulating Tumor Cells in Breast Cancer Follow-up
This study is testing a new way to track cancer cells in the blood of breast cancer patients to see how their condition changes during treatment.
-
Evaluating anticancer drug therapies for gynecologic and breast cancers
This study is testing different cancer drug treatments to see how well they work and how well patients with breast and gynecologic cancers can tolerate them.
-
Digital self-management support to improve quality of life during adjuvant hormonal therapy
This trial tests whether a personalized mobile app plus usual care can help people with early hormone receptor–positive breast cancer have fewer endocrine therapy side effects and better quality of life.
-
Using question prompts to help breast cancer patients before chemotherapy
This study is testing whether a list of questions can help breast cancer patients feel more informed and less anxious before starting chemotherapy.
-
Assessing a genomic classifier for HER2-positive early-stage breast cancer management
This study is testing a new genetic tool to see if it can help predict how well women with early-stage HER2-positive breast cancer will do after treatment with certain therapies.
-
Partial breast reconstruction using chest wall perforator flaps
This study looks at how well partial breast reconstruction using chest wall flaps works for women who have had surgery for early-stage breast cancer.
-
Evaluating HER2DX's impact on treatment decisions for early stage HER2+ breast cancer
This study is testing how the HER2DX test affects treatment choices for patients with early stage HER2+ breast cancer to see if it helps doctors feel more confident in their recommendations.
-
Minimal Scar Mastectomy for Early Stage Breast Cancer
This study tests a new surgery called minimal scar mastectomy for women with early-stage breast cancer who want to avoid reconstruction, to see if it can safely remove cancer while leaving a better appearance.
Related topics
Quick answers
How many Breast Cancer Early Stage Breast Cancer (Stage 1-3) clinical trials are recruiting right now?
26, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in China (5 trials), Italy (4 trials), Spain (3 trials), United Kingdom (2 trials), Sweden (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.